Package 11673-688-25

Brand: olopatadine hydrochloride ophthalmic solution

Generic: olopatadine hydrochloride ophthalmic
NDC Package

Package Facts

Identity

Package NDC 11673-688-25
Digits Only 1167368825
Product NDC 11673-688
Product ID 11673-688_947ab9c4-3102-bae8-2956-0ff85850956c
Description

1 BOTTLE, PLASTIC in 1 CARTON (11673-688-25) / 2.5 mL in 1 BOTTLE, PLASTIC

Marketing

Marketing Status
Marketed Since 2021-09-16
Brand olopatadine hydrochloride ophthalmic solution
Generic olopatadine hydrochloride ophthalmic
Sample Package No

Linked Drug Pages (1)

Olopatadine Hydrochloride Ophthalmic Solution ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "947ab9c4-3102-bae8-2956-0ff85850956c", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["b233bf3d-e6e6-a724-efd9-389b8e36d2f9"], "manufacturer_name": ["Target Corporation"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (11673-688-25)  / 2.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "11673-688-25", "marketing_start_date": "20210916"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "11673-688_947ab9c4-3102-bae8-2956-0ff85850956c", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "11673-688", "generic_name": "Olopatadine Hydrochloride Ophthalmic", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA209752", "marketing_category": "ANDA", "marketing_start_date": "20210916", "listing_expiration_date": "20261231"}